Bruce Wendel

Abraxis Health is establishing as a fully-integrated, next-generation, evidence-based, and personalized healthcare company. It plans to develop a proprietary model for the delivery of healthcare. Abraxis Health is designing and acquiring the necessary infrastructure and plans to acquire and internally develop the hardware and software modules to organize and integrate the data streams that form the foundation of an interactive database. The firm will develop, test, and validate diagnostics and drugs to target pre-selected patients based on molecular profiles that predict drug response to particular therapeutics.

Scientific Protein Laboratories LLC supplies pharmaceutical ingredients. It specializes in cGMP biopharmaceutical manufacturing and commercial supplies. The firm serves the pharmaceutical, veterinary, and food industries. It offers fermentation, natural product extractions, heparin derivatives, and recovery and purification. The company founded in 1976 and is headquartered in Waunakee, WI.

Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL

Part of Bristol Myers Squibb Co., Abraxis BioScience LLC is a company that researches, develops, and manufactures pharmaceutical products for cancer. The company is based in Los Angeles, CA.

Part of KEDRION HOLDING S.P.A., ProMetic BioTherapeutics, Inc. is a company that manufactures plasma protein fractionation products. The company is based in Rockville, MD. ProMetic BioTherapeutics was acquired by Kedrion Biopharma, Inc. on October 18, 2021.

Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL.

Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates.